Effect of hydroxychloroquine in patients with IgA nephropathy with insufficient responses to immunosuppressive therapy: a retrospective case-control study

[1] Rodrigues JC(2017)IgA nephropathy Clin J Am Soc Nephrol 12 677-686

[2] Haas M(2018)Update on treatment of immunoglobulin a nephropathy Nephrology (Carlton) 23 62-67

[3] Reich HN(2018)Corticosteroids in the treatment of IgA nephropathy: any light beyond the clouds of confusion? Postgrad Med J 94 371-373

[4] Zhang YM(2015)Group VsotE-EIW: corticosteroids in IgA nephropathy: a retrospective analysis from the VALIGA study J Am Soc Nephrol 26 2248-2258

[5] Zhang H(2018)Treatment of IgA nephropathy: recent advances and prospects Nephrol Ther 14 S13-S21

[6] Chan TM(2018)A comparison of the effectiveness of cyclophosphamide, leflunomide, corticosteroids, or conservative management alone in patients with IgA nephropathy: a retrospective observational study Sci Rep 8 13662-1890

[7] Tesar V(2018)Efficacy and safety of mycophenolate mofetil for IgA nephropathy: an updated meta-analysis of randomized controlled trials Exp Ther Med 16 1882-1938

[8] Troyanov S(2016)Tacrolimus combined with low-dose corticosteroids is an effective and safe therapeutic option for refractory IgA nephropathy Exp Ther Med 12 1934-1998

[9] Bellur S(2019)Efficacy and safety of leflunomide in IgA nephropathy: a systematic review and meta-analysis Int Urol Nephrol 51 1987-325

[10] Verhave JC(2018)Effects of two immunosuppressive treatment protocols for IgA nephropathy J Am Soc Nephrol 29 317-272

[1] Rodrigues JC(2017)IgA nephropathy Clin J Am Soc Nephrol 12 677-686

[2] Haas M(2018)Update on treatment of immunoglobulin a nephropathy Nephrology (Carlton) 23 62-67

[3] Reich HN(2018)Corticosteroids in the treatment of IgA nephropathy: any light beyond the clouds of confusion? Postgrad Med J 94 371-373

[4] Zhang YM(2015)Group VsotE-EIW: corticosteroids in IgA nephropathy: a retrospective analysis from the VALIGA study J Am Soc Nephrol 26 2248-2258

[5] Zhang H(2018)Treatment of IgA nephropathy: recent advances and prospects Nephrol Ther 14 S13-S21

[6] Chan TM(2018)A comparison of the effectiveness of cyclophosphamide, leflunomide, corticosteroids, or conservative management alone in patients with IgA nephropathy: a retrospective observational study Sci Rep 8 13662-1890

[7] Tesar V(2018)Efficacy and safety of mycophenolate mofetil for IgA nephropathy: an updated meta-analysis of randomized controlled trials Exp Ther Med 16 1882-1938

[8] Troyanov S(2016)Tacrolimus combined with low-dose corticosteroids is an effective and safe therapeutic option for refractory IgA nephropathy Exp Ther Med 12 1934-1998

[9] Bellur S(2019)Efficacy and safety of leflunomide in IgA nephropathy: a systematic review and meta-analysis Int Urol Nephrol 51 1987-325

[10] Verhave JC(2018)Effects of two immunosuppressive treatment protocols for IgA nephropathy J Am Soc Nephrol 29 317-272